Headquartered in Port Jefferson, NY, Symbio Proinnovera is a client-focused global full-service Clinical Research Organization (CRO). We manage all CRO core services in house and have our offices in the USA and Europe. We deliver excellent service and provide experienced qualified personnel to strategically manage all aspects of your clinical trials.
Symbio Proinnovera offers expertise in Proof-of-Concept, medical device and Phase 1 – Phase 4 clinical studies and has completed over 200 clinical studies to date, both in the USA and in Europe.
Developing and maintaining excellent relationships with experienced clinical research sites are vital to the success of any study and every CRO. As a direct result of our site relationships, Symbio Proinnovera trials receive the special attention they deserve. We take great pride in the strong relationships we have established over the years. These relationships have provided us the ability to streamline recruitment, creating shorter enrollment timelines with a lower number of sites.
Our expertise starts from the top. Symbio was founded in 2002 by Richard Panico and Debra Dow. With previous leadership roles in CRO management and product development, Rich and Deb have been able to successfully grow their company by carefully selecting qualified clinical research professionals. In collaboration with senior management, their continued oversight offers clients a personalized experience ensuring study management challenges are anticipated, identified and resolved quickly and efficiently.
The vision from the start has been to create a CRO that consistently delivers outstanding service and quality to sponsors. The common goal is to bring clinical studies to a successful end, on time and on budget.
Our Leadership Team Makes the Difference
Alan Morgan, BSc, FCCA
Chief Executive Officer
“Committed to driving excellence for customers, team members, and broader stakeholders who help us deliver.”
Richard Panico, MBA
Chief Commercial Officer
“The reward for providing great work is being awarded with additional studies and projects. Symbio Proinnovera is here to help Sponsors get studies done – whatever it takes.”
Debra Dow, PharmD, MBA
Chief Operating Officer
“Clinical research is a huge group effort. Our Symbio Proinnovera staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.”
Evyan Cord-Cruz, MD
Director, Medical Affairs/Medical Monitor
“The Medical Affairs group is always available to help ensure the safety of study subjects.”
Christine Künzl, PhD
Director, Medical Writing
“Our experienced Medical Writing team generates customized and high-quality study documents assuring successful submission and well-structured results reporting.”
Peter Bernthaler, PhD
Director, Business Development
“Building bridges, forging connections, and driving growth – that’s the essence of business development.”
Shanna Smith, BS
Executive Director, Global Clinical Operations
“We have an amazing global operations team whose longevity and experience offer our clients consistent, excellent customer service in executing any protocol globally. I am proud of our team and how they navigate challenging situations which allows us to continually strive for excellence.”
Chad Troller, BS, CCRA
Director, Client Services
“There have been tremendous advances in our industry attributable to harnessing the power of technology. But the single most important factor will always remain. People. We owe our success to our partnership with Sponsors, the best Investigators, and by employing the best at Symbio Proinnovera. People are what make the difference.”
Tom McGuire, BS
Director, Business Administration and IT
“Technology enables us to gather data, manage documents and communicate more quickly than ever before. The systems put in place to use these resources are key to greater efficiencies, but they must also be compliant with regulations.”
